Significant Margin Recovery Lifted Ingevity Corporation (NGVT) in Q3

Core Insights - The London Company Small Cap Strategy reported a 1.9% appreciation in its small-cap portfolio for Q3 2025, underperforming the Russell 2000 Index which gained 12.4% [1] - The report highlighted Ingevity Corporation (NYSE:NGVT) as a key holding, noting its significant margin recovery and performance improvements in the Performance Chemicals segment [3] Company Performance - Ingevity Corporation's stock closed at $53.84 on November 3, 2025, with a market capitalization of $1.963 billion [2] - The company achieved a one-month return of 0.71% and a 52-week gain of 24.11% [2] - Ingevity Corporation outperformed its benchmark due to a recovery in margins and strategic portfolio shifts, despite facing a cyclical downturn [3] Hedge Fund Interest - Ingevity Corporation was held by 25 hedge fund portfolios at the end of Q2 2025, an increase from 22 in the previous quarter [4] - While the company shows potential, the report suggests that certain AI stocks may offer greater upside potential with less downside risk [4]